Mohit Kumar Rai

Dr. Mohit Kumar Rai

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications



21 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GSGurvinder Singh
Gurvinder Singh
SASakir Ahmed
Sakir Ahmed
DDDurgesh Dubey
Durgesh Dubey
MRMohit Kumar Rai
Mohit Kumar Rai
ARAtul Rawat
Atul Rawat
DKDinesh Kumar
Dinesh Kumar
Systemic Sclerosis (SSc) is a complex autoimmune disorder characterized by vascular dysfunction, immune dysregulation, and progressive fibrosis of the skin and internal organs. Despite substantial research, its pathophysiology remains enigmatic, necessitating the identification of altered metabolic pathways to improve disease management. This study utilized NMR-based serum metabolomics to identify distinctive metabolic signatures and deranged pathways in SSc. 1D 1H CPMG spectra of sera from 83 SSc patients and 43 age/sex matched HC were measured using 800 MHz NMR. Spectral binning and concentration profiling data were analyzed using multivariate statistical analysis to identify discriminatory metabolic features based variable importance in projection (VIP) scores and mean decrease accuracy (MDA). Univariate statistical analysis and receiver operating characteristic (ROC) curve analysis further evaluated their diagnostic potential. Multivariate analysis revealed clear differentiation between SSc and HC. SSc patients showed decreased levels of alanine, valine, myo-inositol, creatinine, pyruvate, lactate, PUFA, LDL/VLDL, and lipids, alongside elevated levels of acetate, 3-hydroxybutyrate, and mannose. Twelve key metabolites demonstrated high sensitivity and specificity in distinguishing SSc from HC. Pathway analysis revealed disruptions in sugar metabolism, branched-chain amino acids, fatty acid metabolism, and energy metabolism. These findings underscore NMR-based metabolomics as a promising tool for improving SSc diagnosis and understanding its pathogenesis, paving the way for targeted therapeutic strategies.

20 August 2025 in Magnetic Resonance in Chemistry
Verified
Journal Article
Closed access
GSGurvinder Singh
Gurvinder Singh
MRMohit Kumar Rai
Mohit Kumar Rai
VAVikas Agarwal
Vikas Agarwal
DKDinesh Kumar
Dinesh Kumar

27 April 2026 in Indian Heart Journal
Verified
Journal Article
Open access
SMSatya Prasad Mahapatra
Satya Prasad Mahapatra
STSatyendra Tewari
Satyendra Tewari
VAVikas Agarwal
Vikas Agarwal
MRMohit Kumar Rai
Mohit Kumar Rai
HKHarshit Khare
Harshit Khare
AKAditya Kapoor
Aditya Kapoor
Immune-inflammatory processes play a central role in the progression of atherosclerosis. The objective of this study is to evaluate whether circulating microparticles (MPs) correlate with coronary artery disease (CAD) severity defined by SYNTAX Score II in patients aged 45 years. This single-centre, open-label, comparative study enrolled 80 patients with angiographically confirmed CAD (40 aged 45 years) between June 2023 and July 2024. Forty age- and sex-matched individuals with angiographically normal coronary arteries served as the control group. Blood samples were analysed for total MPs, endothelial MPs, platelet-derived MPs, and leukocyte markers (CD45, CD19, CD3, CD16). The study population included a younger cohort in Group I (45 years; mean age 63.9 ± 7.1 years). SYNTAX I and II scores were significantly higher in Group II compared with Group I. Circulating microparticles, including total, endothelial, platelet-derived, CD45+, CD19+, CD3+, and CD16+ microparticles, were significantly elevated in both CAD groups compared with controls, with higher levels observed in Group II. Significant positive correlations were observed between several microparticle subtypes and SYNTAX scores. ROC analysis demonstrated that total microparticles (AUC 0.836) and CD16+ microparticles (AUC 0.856) were the strongest predictors of high SYNTAX II scores. Our study highlights the potential of MPs as biomarkers for early detection and risk stratification of CAD, supporting more personalised and effective treatment strategies.